- Celanese’s first-quarter Adjusted EPS has beat estimates, coming in at $2.08 as compared to $2.01 year over year, and surpassing the estimated $1.91.
- The net sales, however, have dipped by 8.5% year over year at $2.61 billion, which falls short of the estimated $2.68 billion.
- The Engineered Materials Net Sales stand at $1.38 billion, a 15% decrease year over year, undercutting the estimate of $1.51 billion.
- Surprisingly, Acetyl Chain Net Sales have seen a marginal increase of 0.9% year over year at $1.26 billion, bouncing over the estimated $1.18 billion.
- Meanwhile, the operating Ebitda is at $583 million, experiencing a decrease of 2.2% year over year, albeit still beating the estimate which was $573.5 million.
- Forecasts for the second quarter anticipate the adjusted EPS to reside between $2.60 and $3.00, very close to the estimate of $2.87.
- Finally, regarding expert opinions: 6 are encouraging buys, 13 suggest holding, and 5 are recommending sales.
Celanese Corp Series A on Smartkarma
Analyst Coverage of Celanese Corp Series A on Smartkarma
On Smartkarma, analysts from Baptista Research provide insightful coverage of Celanese Corp Series A. In their report titled “Celanese Corporation: Integrated Value Chain Model & 5 Biggest Catalysts For Its Growth! – Major Drivers,” CEO Lori Ryerkerk highlighted expectations for significant improvements in the Materials Solutions business. The report discusses the positive outlook for the company in the first quarter of 2024, with anticipated high EBITDA results driven by lower raw materials costs and a recovery in the auto sector.
In another report, “Celanese Corporation: Overcoming Weak Demand – What’s Their Strategy for Growth? – Major Drivers,” Baptista Research delves into the company’s mixed recent results, with revenues below expectations but strong earnings. The analysis explores the challenges faced by Celanese Corp amidst weak and volatile demand conditions, providing a comprehensive examination of the company’s historical financial performance to understand its future growth strategy.
A look at Celanese Corp Series A Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 2 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on Smartkarma Smart Scores, Celanese Corp Series A shows a promising long-term outlook. The company has received a solid score of 4 for Momentum, indicating strong market performance potential. Additionally, with balanced scores of 3 for Value, Dividend, and Growth, Celanese Corp Series A demonstrates stability and growth prospects. However, the company scores slightly lower with a 2 in Resilience, suggesting some vulnerability to market fluctuations. Overall, Celanese Corp Series A seems well-positioned for future growth and performance.
Celanese Corporation is a global chemical and advanced materials producer, with a product portfolio that includes acetyl, acetate, vinyl emulsion, and engineered polymers. Operating across North America, Europe, and Asia, Celanese Corp Series A appears to have a diversified geographical presence. With its balanced Smart Scores across different factors, the company seems to offer a mix of value, growth potential, and momentum in the market. Despite a slight lower score in Resilience, Celanese Corp Series A‘s overall outlook appears positive for long-term investors.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
